GPR27
Probable G-protein coupled receptor 27
Also known as: GPR27_HUMAN, SREB1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NS67
- Gene
- GPR27
- Ensembl
- ENSG00000170837
- Chromosome
- 3
- Canonical length
- 375 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Actin filaments,Cytosol
OverviewNCBI Gene
GPR27 is a member of the G protein-coupled receptors (GPCRs), a large family of receptors that have a similar structure characterized by 7 transmembrane domains. Activation of GPCRs by extracellular stimuli such as neurotransmitters, hormones, or light induces an intracellular signaling cascade mediated by heterotrimeric GTP-binding proteins, or G proteins.[supplied by OMIM, May 2010]
Canonical amino-acid sequenceUniProt
375 residues, UniProt reviewed canonical sequence.
>Q9NS67|GPR27
1 MANASEPGGS GGGEAAALGL KLATLSLLLC VSLAGNVLFA LLIVRERSLH RAPYYLLLDL
61 CLADGLRALA CLPAVMLAAR RAAAAAGAPP GALGCKLLAF LAALFCFHAA FLLLGVGVTR
121 YLAIAHHRFY AERLAGWPCA AMLVCAAWAL ALAAAFPPVL DGGGDDEDAP CALEQRPDGA
181 PGALGFLLLL AVVVGATHLV YLRLLFFIHD RRKMRPARLV PAVSHDWTFH GPGATGQAAA
241 NWTAGFGRGP TPPALVGIRP AGPGRGARRL LVLEEFKTEK RLCKMFYAVT LLFLLLWGPY
301 VVASYLRVLV RPGAVPQAYL TASVWLTFAQ AGINPVVCFL FNRELRDCFR AQFPCCQSPR
361 TTQATHPCDL KGIGLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GPR27 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 36 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 36 nTPM
- spinal cord: 33 nTPM
- amygdala: 25 nTPM
- hippocampal formation: 22 nTPM
- hypothalamus: 21 nTPM
- midbrain: 20 nTPM
Single-cell type
- neutrophils: 123 nCPM
- neutrophil progenitors: 25 nCPM
- hematopoietic stem cells: 21 nCPM
- monocyte progenitors: 20 nCPM
- megakaryocyte progenitors: 20 nCPM
- pancreatic islet cells: 18 nCPM
Immune cell
- neutrophil: 7.3 nTPM
- eosinophil: 2.8 nTPM
- classical monocyte: 0.5 nTPM
- naive CD4 T-cell: 0.2 nTPM
- intermediate monocyte: 0.1 nTPM
- memory CD4 T-cell: 0.1 nTPM
Brain region
- hypothalamus: 39 nTPM
- basal ganglia: 39 nTPM
- amygdala: 36 nTPM
- spinal cord: 33 nTPM
- hippocampal formation: 33 nTPM
- cerebral cortex: 30 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.05
- gnomAD pLI
- 0.35
- gnomAD missense Z
- 1.6
- DepMap mean gene effect
- 0.16
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of insulin secretion involved in cellular response to glucose stimulus
- positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GPR27 as an antibody target. Whether an autoantibody or antibody against GPR27 could matter depends on whether native GPR27 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GPR27 is annotated at the cell surface, where native GPR27 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GPR27 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...